As of September 26, 2026, ElevenLabs has not filed a registration statement for an initial public offering; no Form S-1 appears for the company on SEC EDGAR, the U.S. Securities and Exchange Commission's public filing database, which covers only U.S. securities filings and would not reflect a listing filed with a non-U.S. regulator or exchange. Bloomberg reported via the Reuters wire on July 2, 2026 that ElevenLabs was exploring an employee stock sale at a valuation of roughly $22 billion, a liquidity event for existing shareholders that is separate from an IPO. More recently, when TechCrunch directly asked ElevenLabs CEO Mati Staniszewski on September 24, 2026 to confirm reports that the company is "looking at 2028 for an IPO," he did not deny it, saying: "We are preparing the foundation to be able to do it in the next years. But whether we do it will depend on the time and place." That is preparation, not a committed date, and no filing has followed the remark.
Segmara is an independent research site. Segmara does not sell, broker, or arrange share purchases. Nothing here is investment advice.
Key points
A stock sale is not a listing
Bloomberg reported on July 2, 2026, via the Reuters wire, that ElevenLabs was exploring an employee stock sale at a valuation of roughly $22 billion. An employee stock sale lets current staff or early shareholders sell existing shares to investors; it moves money between private parties and does not create publicly tradable stock.
That kind of transaction is separate from an initial public offering. It requires no registration statement, no prospectus, and no review by a securities regulator, so its existence says nothing on its own about whether or when ElevenLabs intends to list on an exchange.
The CEO did not say no
On September 24, 2026, TechCrunch asked ElevenLabs CEO Mati Staniszewski directly to confirm reports that the company is 'looking at 2028 for an IPO.' He did not deny it, replying: "We are preparing the foundation to be able to do it in the next years. But whether we do it will depend on the time and place."
That is a statement about preparation, not a commitment. It names no filing date, no exchange, and no underwriter, and it explicitly conditions any IPO on future timing and circumstances that Staniszewski described as undetermined.
What a filing would look like, and what has not happened
A US initial public offering requires a Form S-1 registration statement filed with the SEC and published on SEC EDGAR, the agency's public filing database. As of September 26, 2026, no such filing exists for ElevenLabs on EDGAR. EDGAR covers only US securities filings, so it would not show a listing filed with a different national regulator or exchange either.
Until a filing appears, or ElevenLabs or a regulator states a specific date, any 'ElevenLabs IPO date' circulating online remains speculation. Track SEC EDGAR and ElevenLabs' own statements directly rather than secondary rumors.
AI-ready data summary
A structured extraction layer for this article: catalogue numbers, price context, chart values, and route-specific facts that search and AI systems can read directly from the page.
Metric
Value
Context
Canonical route
/blog/when-will-elevenlabs-ipo
Stable URL path for AI and search extraction.
Article title
When Will ElevenLabs IPO? CEO Won't Deny a 2028 Target
Main page topic.
Attached public sources
2
Number of citation links rendered at the bottom of the article.
Segmara listed companies
51
Live private-company listings in the public catalogue.
Priced listings
37
Catalogue listings with visible indicative or direct marks.
Listings without an indicative price
14
Catalogue listings where a public price is intentionally not invented.
Data fingerprint chart
Visible pricing coverage72%
37 of 51 listings show a mark
Stage
Timing
Price / valuation signal
Interpretation
Chart metric
Score
Interpretation
Visible pricing coverage
72 / 100
37 of 51 listings show a mark
Analytical lens
Search intent
Searches like 'When Will ElevenLabs IPO? CEO Won't Deny a 2028 Target' are research questions: what a filing or a company statement confirms, what has only been reported, and what is still unknown.
What counts as a listing step
For an IPO, the primary record is a registration statement filed with the securities regulator of the listing market, such as an S-1 or F-1 on SEC EDGAR for a US listing. Funding rounds, valuations and secondary-market prices are context, not listing steps.
Segmara role
Segmara is an independent research site. It does not sell, broker, or arrange share purchases, and nothing on this page is investment advice.
How a company reaches a US listing
The SEC filing trail
DraftThe company can first submit a draft registration statement (DRS) for confidential SEC review.
S-1 or F-1The registration statement goes public on SEC EDGAR: Form S-1, or Form F-1 for many foreign companies. A company that used a draft must file publicly at least 15 days before its roadshow.
AmendmentsS-1/A or F-1/A amendments answer SEC comments, and one of them adds the expected price range.
PricingOnce the SEC declares the registration effective, the company sets the price with its underwriters and files the final prospectus, usually a 424B4.
First tradeThe shares start trading on the exchange named in the prospectus, such as Nasdaq or the NYSE.
ElevenLabs is not on Segmara Pro's EDGAR alert list, so no alert is posted for its filings. To look for one, search its name with EDGAR full-text search. Segmara Pro's weekly IPO brief, posted in the members forum, covers filings and pricing across the IPO calendar.
No S-1 or F-1 appears for ElevenLabs on SEC EDGAR as of the latest site review. Bloomberg reported via the Reuters wire on July 2, 2026 that the company was exploring an employee stock sale at a valuation of roughly $22 billion, a private secondary transaction involving existing shares, not a public offering.
Asked directly by TechCrunch on September 24, 2026 to confirm reports that ElevenLabs is 'looking at 2028 for an IPO,' CEO Mati Staniszewski did not deny it, saying: "We are preparing the foundation to be able to do it in the next years. But whether we do it will depend on the time and place."
Staniszewski's answer describes preparation, not a scheduled listing date or a filing; taken with the roughly $22 billion valuation Bloomberg reported nearly three months earlier, it shows a company gaining scale while stopping short of confirming when, or whether, it will go public.
Risk notes
Rumor risk: unofficial dates, valuations, or funding details circulating on social media or forums are frequently wrong or outdated and should not be treated as confirmation of anything.
Illiquidity risk: any private-market interest, indicative marks, or pre-IPO share arrangements in a company that has not listed can be difficult to exit and may not reflect a tradable price.
Timing risk: a company can pause, restart, or abandon IPO preparation at any stage, including after a confidential or public filing, so no step before pricing guarantees a listing.
Free: every article, the IPO calendar and the weekly IPOs page. Segmara Pro posts a weekly IPO brief in the members forum. 7-day free trial, then $15 a month (plus any applicable tax). Research only, no share sales.
Can retail investors track private-company shares on Segmara?
Yes. The free pre-IPO tracker sends indicative marks by email, with no card and no documents. Segmara does not sell, broker, or arrange share purchases.
Why was this market historically hard for retail investors to reach?
Private-company share access has often moved through private equity firms, venture funds, insiders, institutions, and relationship-driven secondary networks. Segmara makes research simpler: anyone can follow named private companies for free, by email.
What is the easiest next step?
Open the free pre-IPO tracker first, email only. The IPO calendar is free, and Segmara Pro adds a weekly IPO brief.
Has ElevenLabs confirmed an IPO date?
No. As of the latest site review, no Form S-1 or other registration statement has been filed with the SEC or any other regulator. When TechCrunch asked CEO Mati Staniszewski directly on September 24, 2026 whether a reported 2028 target was accurate, he did not deny it but did not name a date either, saying: "We are preparing the foundation to be able to do it in the next years. But whether we do it will depend on the time and place."
What is ElevenLabs worth?
The most recent figure comes from Bloomberg, reported via the Reuters wire on July 2, 2026: ElevenLabs was said to be exploring an employee stock sale at a valuation of roughly $22 billion. That figure is tied to a specific transaction reportedly under discussion, not an audited or company-confirmed valuation.
Is an employee stock sale the same as an IPO?
No. An employee stock sale, often called a tender offer, lets current employees or early shareholders sell existing shares to investors in a private transaction. It does not involve a public listing, a stock exchange, or a registration statement filed with a securities regulator. The July 2026 report describes this kind of private sale, not a public offering.
Can I buy ElevenLabs shares before the IPO?
Not through a public exchange, since ElevenLabs has not filed to go public. Any private-share offer you encounter should be verified independently before you rely on it. Segmara does not sell, broker, or arrange purchases of ElevenLabs shares.
Next step
Track private-market prices free.
If this article helped explain ElevenLabs, start with the free tracker: indicative pre-IPO marks by email. No card, no documents, no brokerage account.
Segmara is an independent research site. Segmara does not sell, broker, or arrange share purchases.